Jishizhan Chen

Yang Zhou, Kunhao Yuan, Ye Wei et al.

Liver fibrosis represents the accumulation of excessive extracellular matrix caused by sustained hepatic injury. It disrupts normal lobular architecture and function, increasing the chances of cirrhosis and liver failure. Precise staging of fibrosis for early diagnosis and intervention is often invasive, which carries risks and complications. To address this challenge, recent advances in artificial intelligence-based liver segmentation and fibrosis staging offer a non-invasive alternative. As a result, the CARE 2025 Challenge aimed for automated methods to quantify and analyse liver fibrosis in real-world scenarios, using multi-centre, multi-modal, and multi-phase MRI data. This challenge included tasks of precise liver segmentation (LiSeg) and fibrosis staging (LiFS). In this study, we developed an automated pipeline for both tasks across all the provided MRI modalities. This pipeline integrates pseudo-labelling based on multi-modal co-registration, liver segmentation using deep neural networks, and liver fibrosis staging based on shape, textural, appearance, and directional (STAD) features derived from segmentation masks and MRI images. By solely using the released data with limited annotations, our proposed pipeline demonstrated excellent generalisability for all MRI modalities, achieving top-tier performance across all competition subtasks. This approach provides a rapid and reproducible framework for quantitative MRI-based liver fibrosis assessment, supporting early diagnosis and clinical decision-making. Code is available at https://github.com/YangForever/care2025_liver_biodreamer.

Zonglin Yang, Xiaolei Diao, Jishizhan Chen et al.

Early and accurate diagnosis and lesion localization of bone infections are crucial for clinical treatment. PET-CT integrates anatomical information from CT with metabolic information from PET, making it an important imaging modality for diagnosing bone infections. However, accurate lesion segmentation remains challenging due to indistinct lesion boundaries and inconsistencies in annotations generated by different experts or automated systems. In this work, we investigate multimodal segmentation of bone infections under annotation discrepancy. We develop a bimodal end-to-end segmentation framework that integrates PET metabolic signals and CT bone-window anatomy through an early-fusion multimodal representation.To mitigate performance inflation caused by inter-slice correlation in small datasets, this study discards traditional two-dimensional evaluation methods and implements a rigorous patient-level 3D volumetric evaluation and cross-validation. Furthermore, instead of forcing a singular consensus, we propose a decoupled dual-source learning framework where parallel models are trained on independent expert annotations driven by high-sensitivity and high-specificity clinical intents. Experimental results objectively report performance variations at the patient level (Mean + SD and Mean - SD), demonstrating the effectiveness of multimodal PET-CT fusion. The cross-evaluation matrix quantitatively reveals how models successfully internalize distinct expert diagnostic philosophies, providing a robust, diversity-preserving paradigm for clinical AI deployment in bone infection segmentation.

Daqian Shi, Pei Han, Jishizhan Chen et al.

Chronic osteomyelitis presents substantial prognostic challenges due to its high recurrence risk and complex postoperative recovery trajectories. Traditional assessment often relies on manual scoring systems, which limit scalability, efficiency, and consistency in clinical practice. Furthermore, the heterogeneous nature of clinical data poses challenges for current multimodal learning approaches that require aligned inputs and large annotated datasets. In this work, we propose RAG4Outcome, a retrieval-augmented generation (RAG) framework for prognostic prediction in chronic osteomyelitis. Our method integrates multimodal clinical data, including PET-CT imaging reports, structured surgical and diagnostic records, and unstructured follow-up notes, into a unified prediction pipeline. By combining a domain-specific retrieval corpus with expert-guided prompting, the framework enables more interpretable, evidence-grounded, and clinically reliable prognosis. Preliminary results on real-world cases demonstrate promising effectiveness and clinical alignment, highlighting the potential of RAG4Outcome for AI-assisted infection management and postoperative decision support.

Jishizhan Chen, Qingzeng Zhang

The rapid integration of artificial intelligence (AI) into healthcare is transforming clinical decision-making and hospital operations. DeepSeek has emerged as a leading AI system, widely deployed across China's tertiary hospitals since January 2025. Initially implemented in Shanghai's major medical institutions, it has since expanded nationwide, enhancing diagnostic accuracy, streamlining workflows, and improving patient management. AI-powered pathology, imaging analysis, and clinical decision support systems have demonstrated significant potential in optimizing medical processes and reducing the cognitive burden on healthcare professionals. However, the widespread adoption of AI in healthcare raises critical regulatory and ethical challenges, particularly regarding accountability in AI-assisted diagnosis and the risk of automation bias. The absence of a well-defined liability framework underscores the need for policies that ensure AI functions as an assistive tool rather than an autonomous decision-maker. With continued technological advancements, AI is expected to integrate multimodal data sources, such as genomics and radiomics, paving the way for precision medicine and personalized treatment strategies. The future of AI in healthcare depends on the development of transparent regulatory structures, industry collaboration, and adaptive governance frameworks that balance innovation with responsibility, ensuring equitable and effective AI-driven medical services.